CLASS III Drug recall · Reported 22 Sep 2021 · FDA Enforcement Report
Candesartan Cilexetil Tablets, USP 16 mg recalled by Viatris
Viatris is recalling Candesartan Cilexetil Tablets, USP 16 mg, distributed nationwide in the US. The recall was initiated on 13 Sep 2021 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0798-2021
- FDA event ID
- 88609
- Recalling firm
- Viatris, Morgantown, WV
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 13 Sep 2021
- FDA classified
- 14 Sep 2021
- Reported
- 22 Sep 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Blood Pressure Medication
Timeline
| 13 Sep 2021 | Recall initiated by company | |
| 14 Sep 2021 | Classified by FDA | +1 day |
| 22 Sep 2021 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Impurities/Degradation Specifications; out of specification for Related Compound
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93
Where it was distributed
Product was distributed nationwide.
Questions about this recall
Why was it recalled?
Failed Impurities/Degradation Specifications; out of specification for Related Compound
Which lots are affected?
Lot # 3107334, exp. date October 2021
Where was it sold?
Product was distributed nationwide.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Viatris
All 26| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg recalled by ViatrisTelmisartan And Amlodipine | Viatris | Potency & Assay | Nationwide |
| Drug | CLASS II | Xanax XR, alprazolam, extended-release tablets, 3 mg recalled by Viatris | Viatris | Potency & Assay | Nationwide |
| Drug | CLASS II | Cardura XL (doxazosin) extended release tablets 4 mg recalled by ViatrisCardura | Viatris | Potency & Assay | Nationwide |
| Drug | CLASS II | Cardura XL (doxazosin) extended release tablets 8 mg recalled by ViatrisCardura | Viatris | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothyroxine Sodium Tablets USP, 25 mcg recalled by Viatris | Viatris | Potency & Assay | Nationwide |
Other Candesartan Cilexetil recalls
All 11| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Candesartan Cilexetil and Hydrochlorothiazide Tablets recalledCandesartan Cilexetil And Hydrochlorothiazide | Mylan Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Candesartan Cilexetil Tablets, 16 mg, a) recalled by Sandoz | Sandoz | Potency & Assay | Nationwide |
| Drug | CLASS III | Candesartan Cilexetil Tablets, 16 mg (5 x, Rx recalled | Amerisource Health Services | Potency & Assay | Nationwide |
| Drug | CLASS III | candesartan cilexetil, tablets, 16 mg recalled by Sandoz | Sandoz | Potency & Assay | Nationwide |
| Drug | CLASS III | Candesartan Cilexetil Tablets, 8 mg recalled by Apotex | Apotex | Potency & Assay | Nationwide |